Cargando…
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Success in anticancer immune therapy relies on stimulation of tumor antigen‐specific T lymphocytes and effective infiltration of the T cells into tumor tissue. Here, a therapeutic vaccine that promotes proliferation and tumor infiltration of antigen‐specific T cells in both inflamed and noninflamed...
Autores principales: | Mai, Junhua, Li, Zhaoqi, Xia, Xiaojun, Zhang, Jingxin, Li, Jun, Liu, Haoran, Shen, Jianliang, Ramirez, Maricela, Li, Feng, Li, Zheng, Yokoi, Kenji, Liu, Xuewu, Mittendorf, Elizabeth A., Ferrari, Mauro, Shen, Haifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224417/ https://www.ncbi.nlm.nih.gov/pubmed/34194942 http://dx.doi.org/10.1002/advs.202100166 |
Ejemplares similares
-
Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis
por: Shen, Qi, et al.
Publicado: (2018) -
An mRNA vaccine elicits STING-dependent antitumor immune responses
por: Chen, Zhe, et al.
Publicado: (2023) -
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
por: Liu, Haoran, et al.
Publicado: (2018) -
Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells
por: Tian, Shaohui, et al.
Publicado: (2022) -
Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer
por: Li, Jun, et al.
Publicado: (2019)